June 10, 2025: EMA Finds Rybelsus Increases the Risk of Eye Strokes and Vision Loss After reviewing non-clinical studies, clinical trials, post-marketing surveillance, and medical literature, the European Medicines Agency (EMA) has determined that Rybelsus increases a persons risk of developing NAION
Chhote Lal Address Building No
The safest assumption is that effectiveness is possible but not guaranteed, and it should be confirmed with careful titration, symptom tracking, and objective measures such as waist change and glycemic markers when relevant
In the SURMOUNT 1 Trial (pooling doses), total lean mass was reduced by 8.5 absolute percentage points [15]
Mistake 4: Rubbing the injection site The instinct to rub the spot after an injection is natural but counterproductive